Study of FFI-1010 in Pediatric Kidney Disease

NCT03345316 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Children Under 18 Years Old With Kidney Disease

Interventions

DRUG: FFI-1010

Sponsor

Fuji Yakuhin Co., Ltd.